医疗诊断服务提供商Labcorp收购临床诊断服务提供商BioReference Health精选资产-动脉橙

医疗诊断服务提供商Labcorp收购临床诊断服务提供商BioReference Health精选资产

2024-03-28 CISION 等4家媒体报道收购





Labcorp和OPKO Health已达成协议，Labcorp将收购BioReference Health的实验室检测业务，该业务专注于美国（不包括纽约和新泽西州）的临床诊断、生殖和女性健康。收购价格为2.375亿美元，收购的资产目前每年产生约1亿美元的收入。此次收购符合Labcorp的战略和财务目标。（摘要由动脉网AI生成）

关联公司

 LabCorpBio-Reference Laboratories

2024-03-28 Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

CISION
2024-03-28 Labcorp To Acquire Select Assets Of BioReference Health - Quick Facts

RTTNews
2024-03-28 Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

BioSpace
2024-03-29 Labcorp’s $237M Tuck-In Deal Brings Lab Testing Assets From BioReference Health

MedCity News